|
|
 |
|
| Conferences |
- P. Alard (2010) Improving antibodies properties by rational in silico engineering: a realistic perspective, Peptalk 2010, San Diego.
|
| Patents |
- S. Loverix, P. Alard, S. Deroo, K. Somers, I. Lasters, J. Desmet (February 20, 2017) Polypeptides capable of cellular internalization Appl. No. DK20130788700T 20131022 Complix N.V.
- J. Meijberg, A. Impagliazzo, R. Vogels, R. Friesen, P. Alard, S. Loverix, K. Radosevic (November 27, 2012) Influenza virus vaccines and uses thereof. US Patent Appl. No. 14/361,281 Janssen Vaccines & Prevention
- V. Germaschewski, A. Lewis, T. Wattam, P. Soden, P. Alard, J. Ellis; S. Ford; P. Thomas; G. Gough; I. Catchpole (December 11, 2007) Antigen Binding Proteins. GB Patent Appl. No. 0724185.4 Glaxo group ltd
|
| Publications |
- P. Alard, J. Desmet, I.Lasters (2010) In silico de-immunization. Chapter 24 of Antibody Engineering Eds R. Kontermann, S. Dubel Springer-Verlag, 369-376.
- M. Throsby, E. van den Brink, M. Jongeneelen, L.L. Poon, P. Alard et al. (2008). Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3, e3942.
- R. Barderas, J. Desmet, P. Alard, J. Casal (2012) Affinity maturation by semi-rational approaches. Methods Mol. Biol. 907, 463-486.
- V.V. Kapoerchan, M. Wiesner, U. Hillaert, J.W. Drijfhout, M. Overhand, P. Alard, G.A. van der Marel, H.S. Overkleeft, F. Koning (2010). Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule. Mol. Immunol. 47, 1091-1097.
- K. Himanen, M. Vuylsteke, S. Vanneste, S. Vercruysse, E. Boucheron, P. Alard, D. Chriqui, M. Van Montagu, D. Inzé, and T. Beeckman (2004). Transcript profiling of early lateral root initiation. Proc. Natl. Acad. Sci. USA 101, 5146-5151.
|
|
|
|
|
